{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:23:18Z","timestamp":1789687398393,"version":"4.0.1"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/ajg.2015.203","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T08:01:02Z","timestamp":1438070462000},"page":"1169-1177","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prevalence of Cirrhosis in Hepatitis C Patients in the Chronic Hepatitis Cohort Study (CHeCS): A Retrospective and Prospective Observational Study"],"prefix":"10.14309","volume":"110","author":[{"given":"Stuart C","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois E","family":"Lamerato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loralee B","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R","family":"Spradling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyasu","family":"Teshale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A","family":"Boscarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinutha","family":"Vijayadeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Oja-Tebbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210210","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.","volume":"160","author":"Denniston","year":"2014","journal-title":"Ann Intern Med"},{"key":"R2-15-20210210","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199212313272703","article-title":"Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.","volume":"327","author":"Seeff","year":"1992","journal-title":"N Engl J Med"},{"key":"R4-15-20210210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2009.09.067","article-title":"Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.","volume":"138","author":"Davis","year":"2010","journal-title":"Gastroenterology"},{"key":"R5-15-20210210","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1053\/j.gastro.2010.12.032","article-title":"Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.","volume":"140","author":"Kanwal","year":"2011","journal-title":"Gastroenterology"},{"key":"R6-15-20210210","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/j.1572-0241.2006.00682.x","article-title":"More advanced hepatic fibrosis in hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis.","volume":"101","author":"Verma","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R7-15-20210210","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cgh.2009.08.009","article-title":"Ethnicity and body mass index are associated with hepatitis C presentation and progression.","volume":"8","author":"Kallwitz","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R8-15-20210210","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ajg.2014.214","article-title":"Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.","volume":"109","author":"El-Serag","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R9-15-20210210","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/lt.23376","article-title":"Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.","volume":"18","author":"Verna","year":"2012","journal-title":"Liver Transpl"},{"key":"R10-15-20210210","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.","volume":"33","author":"Adinolfi","year":"2001","journal-title":"Hepatology"},{"key":"R11-15-20210210","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/j.1572-0241.2002.05995.x","article-title":"Contribution of obesity to hepatitis C-related fibrosis progression.","volume":"97","author":"Ortiz","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R12-15-20210210","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"key":"R13-15-20210210","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1572-0241.2008.01813.x","article-title":"Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.","volume":"103","author":"Petta","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R14-15-20210210","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.27212","article-title":"Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study.","volume":"60","author":"Huang","year":"2014","journal-title":"Hepatology"},{"key":"R15-15-20210210","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/cid\/ciu077","article-title":"Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010.","volume":"58","author":"Mahajan","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R16-15-20210210","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.","volume":"48","author":"Thein","year":"2008","journal-title":"Hepatology"},{"key":"R17-15-20210210","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.25842","article-title":"Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.","volume":"56","author":"Gordon","year":"2012","journal-title":"Hepatology"},{"key":"R18-15-20210210","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIVHCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R20-15-20210210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest.","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"R21-15-20210210","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cid\/cit245","article-title":"Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.","volume":"57","author":"Holmberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R22-15-20210210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cid\/cis815","article-title":"Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study.","volume":"56","author":"Moorman","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R23-15-20210210","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jvh.12224","article-title":"The validity of serum markers for fibrosis staging in chronic hepatitis B and C.","volume":"21","author":"Li","year":"20114","journal-title":"J Viral Hepat"},{"key":"R24-15-20210210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R25-15-20210210","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"R26-15-20210210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"R27-15-20210210","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C.","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"key":"R28-15-20210210","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1053\/j.gastro.2008.02.069","article-title":"Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors.","volume":"134","author":"Missiha","year":"2008","journal-title":"Gastroenterology"},{"key":"R29-15-20210210","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10620-011-1908-3","article-title":"Histological versus clinical cirrhosis in chronic hepatitis C: does raceethnicity really matter?","volume":"57","author":"Kohla","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R30-15-20210210","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1572-0241.2002.05555.x","article-title":"Hepatitis C infection in African Americans: its natural history and histological progression.","volume":"97","author":"Wiley","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R31-15-20210210","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/hep.1840180609","article-title":"The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use.","volume":"18","author":"Gordon","year":"1993","journal-title":"Hepatology"},{"key":"R32-15-20210210","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.510280238","article-title":"Clinical outcome of hepatitis C as a function of mode of transmission.","volume":"28","author":"Gordon","year":"1998","journal-title":"Hepatology"},{"key":"R33-15-20210210","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/MCG.0b013e31818be17c","article-title":"Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients.","volume":"43","author":"Hu","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R34-15-20210210","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1155\/2010\/692036","article-title":"Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.","volume":"24","author":"Livingston","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"R35-15-20210210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.27095","article-title":"HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV.","volume":"60","author":"Kanwal","year":"2014","journal-title":"Hepatology"},{"key":"R36-15-20210210","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cgh.2013.09.062","article-title":"Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.","volume":"12","author":"Gordon","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R37-15-20210210","doi-asserted-by":"crossref","first-page":"531","DOI":"10.18553\/jmcp.2011.17.7.531","article-title":"All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective.","volume":"17","author":"McAdam-Marx","year":"2011","journal-title":"J Manag Care Pharm"},{"key":"R38-15-20210210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hep.27151","article-title":"Cost analysis of sofosbuvirribavirin versus sofosbuvirsimeprevir for genotype 1 hepatitis C virus in interferon-ineligibleintolerant individuals.","volume":"60","author":"Hagan","year":"2014","journal-title":"Hepatology"},{"key":"R39-15-20210210","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1002\/hep.27010","article-title":"Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.","volume":"59","author":"Petta","year":"2014","journal-title":"Hepatology"},{"key":"R40-15-20210210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/apt.12871","article-title":"Cost-effectiveness analysis of sofosbuvir plus peginterferonribavirin in the treatment of chronic hepatitis C virus genotype 1 infection.","volume":"40","author":"Saab","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"R41-15-20210210","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/hep.1840140603","article-title":"Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.","volume":"14","author":"Di Bisceglie","year":"1991","journal-title":"Hepatology"},{"key":"R42-15-20210210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.7326\/0003-4819-119-2-199307150-00003","article-title":"Non-A, non-B post-transfusion hepatitis. Looking back in the second decade.","volume":"119","author":"Koretz","year":"1993","journal-title":"Ann Intern Med"},{"key":"R43-15-20210210","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0676.1993.tb00644.x","article-title":"Outcome of acute symptomatic non-A, non-B hepatitis: a 13-year follow-up study of hepatitis C virus markers.","volume":"13","author":"Mattsson","year":"1993","journal-title":"Liver"},{"key":"R44-15-20210210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0168-8278(05)80657-9","article-title":"Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis.","volume":"16","author":"Tremolada","year":"1992","journal-title":"J Hepatol"},{"key":"R45-15-20210210","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1056\/NEJM199909163411202","article-title":"Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.","volume":"341","author":"Vogt","year":"1999","journal-title":"N Engl J Med"},{"key":"R46-15-20210210","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","article-title":"Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.","volume":"340","author":"Kenny-Walsh","year":"1999","journal-title":"N Engl J Med"},{"key":"R47-15-20210210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/jhep.2000.8169","article-title":"Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study.","volume":"32","author":"Wiese","year":"2000","journal-title":"Hepatology"},{"key":"R48-15-20210210","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/jhep.2000.9714","article-title":"Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.","volume":"32","author":"Rodger","year":"2000","journal-title":"Hepatology"},{"key":"R49-15-20210210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-132-2-200001180-00003","article-title":"45-year follow-up of hepatitis C virus infection in healthy young adults.","volume":"132","author":"Seeff","year":"2000","journal-title":"Ann Intern Med"},{"key":"R50-15-20210210","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors.","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"R51-15-20210210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/jhep.2001.21905","article-title":"Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study.","volume":"33","author":"Seeff","year":"2001","journal-title":"Hepatology"},{"key":"R52-15-20210210","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/liv.12327","article-title":"Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.","volume":"34","author":"Cales","year":"2014","journal-title":"Liver Int"},{"key":"R53-15-20210210","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3748\/wjg.v20.i11.2854","article-title":"Non-invasive diagnosis of liver fibrosis in chronic hepatitis C.","volume":"20","author":"Schiavon Lde","year":"2014","journal-title":"World J Gastroenterol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2015203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2015203","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2015203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201508000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:01:10Z","timestamp":1786543270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201508000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2015.203","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}